Overview
Our company, StemBio Innovations, is at the forefront of revolutionizing the field of regenerative medicine with our proprietary stem cell therapy platform. Our technology focuses on harnessing the regenerative potential of stem cells to create treatments for degenerative diseases such as Alzheimer’s and Parkinson’s. Since our establishment in 2024, we have made significant progress in developing our product, receiving preliminary FDA approval for our clinical trials. With a dedicated team of experienced scientists and medical professionals, we have successfully conducted initial trials that demonstrated the potential of our technology, showing positive results in a small cohort of patients. However, to take our product to the next level and enter Phase 2 of clinical trials, we are seeking an investment of $220,000. Our goal is to secure funding to operationalize our clinical trials, build partnerships with leading hospitals, and expand our research team. The need for innovative treatments for degenerative diseases is more pressing than ever, and our platform is positioned to meet this demand. The aging population globally and the increasing prevalence of these diseases present a s…
Use of funds
The investment will primarily be allocated to:
- Clinical trial expenses: $120,000
- Hiring additional research staff: $50,000
- Marketing and partnership development: $30,000
- Operational overheads and regulatory costs: $20,000
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.